menu search

CLVS / Clovis: Shifting Toward Nuclear Medicine

Clovis: Shifting Toward Nuclear Medicine
Clovis, a "trading stock," has some shakiness in its fundamentals. Moreover, the shares tend to rise and fall for you to trade for short-term gains. Due to upcoming catalysts in June, Clovis is a trading stock that is about to embark on another bullish cycle. Read More
Posted: Apr 25 2022, 12:33
Author Name: Seeking Alpha
Views: 110735

CLVS News  

Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid

By Zacks Investment Research
December 12, 2022

Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid

Recent regulatory developments force Clovis (CLVS) to file for bankruptcy. The company inks a stalking horse agreement with Novartis for one of its pi more_horizontal

CLVS Stock Alert: What to Know as Clovis Oncology Files for Bankruptcy

By InvestorPlace
December 12, 2022

CLVS Stock Alert: What to Know as Clovis Oncology Files for Bankruptcy

Clovis Oncology (NASDAQ: CLVS ) stock is on the move Monday as investors react to the pharmaceutical company filing for bankruptcy protection. The fir more_horizontal

Clovis Oncology stock slides 10% premarket after company files for bankruptcy

By Market Watch
December 12, 2022

Clovis Oncology stock slides 10% premarket after company files for bankruptcy

Clovis Oncology Inc. stock CLVS, -9.94% fell 10% in premarket trade Monday, after the biotech filed for Chapter 11 bankruptcy and said it would sell a more_horizontal

Dear CLVS Stock Fans, Get Ready for a Bankruptcy Filing

By InvestorPlace
December 5, 2022

Dear CLVS Stock Fans, Get Ready for a Bankruptcy Filing

Investors in Clovis Oncology (NASDAQ: CLVS ) stock will want to prepare for a bankruptcy filing following a warning from the pharmaceutical company. A more_horizontal

Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why

By Zacks Investment Research
November 25, 2022

Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why

Clovis Oncology (CLVS) tanks in the past six months following the possibility of a bankruptcy filing in the near term. more_horizontal

Down 67.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Clovis (CLVS)

By Zacks Investment Research
November 21, 2022

Down 67.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Clovis (CLVS)

Clovis (CLVS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong a more_horizontal

Clovis Oncology (CLVS) Stock Pops After Bankruptcy Warning

By InvestorPlace
November 14, 2022

Clovis Oncology (CLVS) Stock Pops After Bankruptcy Warning

There's nothing like a good old-fashioned bankruptcy warning to make a stock pop on a given day. Today, the latest speculative frenzy appears to be un more_horizontal

Clovis (CLVS) Down 12.6% Since Last Earnings Report: Can It Rebound?

By Zacks Investment Research
September 7, 2022

Clovis (CLVS) Down 12.6% Since Last Earnings Report: Can It Rebound?

Clovis (CLVS) reported earnings 30 days ago. What's next for the stock? more_horizontal


Search within

Pages Search Results: